Can molecular stratification improve the treatment of inflammatory bowel disease?

Inflammatory bowel disease (IBD) is a debilitating chronic inflammatory disease of the gastrointestinal (GI) tract. It affects more than 3.5 million people in the western world and places a huge financial burden on healthcare systems. IBD is highly heterogeneous; disease severity and outcomes in IBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Claire, Baer, Hannah M., Gaya, Daniel R., Nibbs, Robert J.B., Milling, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902263/
https://www.ncbi.nlm.nih.gov/pubmed/31491469
http://dx.doi.org/10.1016/j.phrs.2019.104442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902263/
https://www.ncbi.nlm.nih.gov/pubmed/31491469
http://dx.doi.org/10.1016/j.phrs.2019.104442

Ejemplares similares